Literature DB >> 14962469

The first minutes of reperfusion: a window of opportunity for cardioprotection.

H M Piper1, Y Abdallah, C Schäfer.   

Abstract

During the past decade, the understanding has grown that control of the conditions of reperfusion is critical for salvaging ischemic-reperfused myocardium. The first few minutes of reperfusion constitute a critical phase, as here lethal tissue injury in addition to that already developed during ischemia may be initiated. The identification of the mechanisms of reperfusion-induced cell death opens a new window of opportunity for cardioprotection in the clinic. Development of cardiomyocyte hypercontracture is a predominant feature of reperfusion injury. We and others have shown that control of hypercontracture in reperfusion reduces the extent of tissue injury. On the cellular level, it was shown that reperfusion-induced hypercontracture might either originate from a rigor-type mechanism, when energy recovery proceeds very slowly, or from Ca2+ overload, when energy recovery is rapid but cytosolic Ca2+ load is high. These two mechanisms can be influenced by various interventions that either connect with cytosolic Ca2+ control or myofibrillar Ca2+ sensitivity or with mitochondrial energy production. These experimental approaches will hopefully lead to novel strategies for clinical cardioprotection during the early phase of reperfusion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962469     DOI: 10.1016/j.cardiores.2003.12.012

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  75 in total

1.  Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone.

Authors:  S Cumero; F Fogolari; R Domenis; R Zucchi; I Mavelli; S Contessi
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 2.  Mitochondrial medicine: pharmacological targeting of mitochondria in disease.

Authors:  J S Armstrong
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

3.  Maintaining cooperation among cardiac myofilament proteins through thick and thin.

Authors:  R John Solaro
Journal:  J Physiol       Date:  2009-01-15       Impact factor: 5.182

4.  Rat intermedin1-47 does not improve functional recovery in postischemic hearts.

Authors:  Gerald Münzel; Alexander Schlier; Rolf Schreckenberg; Yaser Abdallah; Klaus-Dieter Schlüter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-01       Impact factor: 3.000

Review 5.  Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion.

Authors:  Giancarlo Solaini; David A Harris
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

6.  Carnitine worsens both injury and recovery of contractile function after transient ischemia in perfused rat heart.

Authors:  R Díaz; J Lorita; M Soley; I Ramírez
Journal:  J Physiol Biochem       Date:  2008-03       Impact factor: 4.158

7.  Structural and kinetic effects of hypertrophic cardiomyopathy related mutations R146G/Q and R163W on the regulatory switching activity of rat cardiac troponin I.

Authors:  Zhiqun Zhou; Daniel Rieck; King-Lun Li; Yexin Ouyang; Wen-Ji Dong
Journal:  Arch Biochem Biophys       Date:  2012-12-13       Impact factor: 4.013

8.  Reperfusion and calculated RISKs: pharmacological postconditioning of human myocardium.

Authors:  G F Baxter; D S Burley
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

9.  Long-term protection and mechanism of pacing-induced postconditioning in the heart.

Authors:  Fawzi A Babiker; Ilka Lorenzen-Schmidt; Eric Mokelke; Ward Y Vanagt; Tammo Delhaas; Johannes Waltenberger; Jack P Cleutjens; Frits W Prinzen
Journal:  Basic Res Cardiol       Date:  2010-03-25       Impact factor: 17.165

10.  Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition.

Authors:  Takayuki Miki; Tetsuji Miura; Hiroyuki Hotta; Masaya Tanno; Toshiyuki Yano; Takahiro Sato; Yoshiaki Terashima; Akifumi Takada; Satoko Ishikawa; Kazuaki Shimamoto
Journal:  Diabetes       Date:  2009-09-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.